Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Reflections on COVID-19 Driven Telehealth Implementation in the RWHAP
The HRSA white page Innovation and Resilience: How Ryan White HIV/AIDS Program Recipients Leverage Telehealth during the COVID-19 Pandemic offers lessons for future service delivery.Blog updated 01/23/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
An Update on COVID-19
Review of COVID-19 risks in people with HIV (PWH), covering: risks; vaccination and prevention measures; and treatment considerations.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Cases From the Clinic(ians): Antiretroviral Therapy Cases and Panel Discussion
Insights for clinicians on selecting antiretroviral therapy and/or managing patients who: are starting initial therapy; are Elite Controllers; have InSTI-associated weight gain; have persistent low-level viremia; have a discordant CD4+ count response to ART; have ‘Blips’; and/or are aging.Resource (Conference Presentation) updated 04/08/2024
-
Preventing HIV-Related Comorbidities in Adolescents
Review of the epidemiology of adolescents living with HIV; risk factors for developing comorbidities over the life course among adolescents with HIV; and opportunities to prevent comorbidities and optimize outcomes.Resource (Conference Presentation) updated 09/14/2023
-
An Update on Screening for Non-AIDS-Defining Cancers
Review of overall trends, increased incidence, and screening regarding non-AIDS-defining cancers for people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
Addressing Depression In People with HIV
Review of the differential diagnosis, management and treatment of depressive illnesses among people with HIV.Resource (Conference Presentation) updated 09/14/2023
-
Diagnosing and Managing Sexually Transmitted Infections
Review of the diagnostic and management strategies for the most common sexually transmitted infections based on the updated 2021 CDC STI Treatment Guidelines.Resource (Conference Presentation) updated 09/14/2023
-
Preexposure Prophylaxis: A Case-Based Panel Discussion
Review of options for PrEP in patients with decreased kidney function and low bone mineral density; the state of the science on STI prevention strategies; and recent data on the safety and efficacy on injectable PrEP options.Resource (Conference Presentation) updated 09/14/2023
-
Expanded Access to Subsidized Marketplace Insurance Plans
Did you know? Most people with very low incomes can now enroll in subsidized Marketplace coverage.Blog updated 04/14/2022
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022
-
Make a Difference: How PC/PBs Can Strengthen The HIV System of Care
Overview of the HIV system of care and how PC/PBs can help strengthen it.Resource updated 01/05/2024
-
Chicago Area HIV Integrated Services Council
-
National Monitoring Standards and RWHAP Part B Manual Recipients
This HRSA technical assistance webinar provided a high level overview of updates made to both the National Monitoring Standards (NMS) and the Ryan White HIV/AIDS Program (RWHAP) Part B Manual. Release of the NMS is forthcoming.Resource updated 08/21/2023
-
Ryan White HIV/AIDS Program Part A Community Planning: Ways for People with Lived Experience to Participate
Infographic showing the many different ways that people with HIV can be involved with planning council activities:Resource updated 09/19/2023
-
Imagine: Ending HIV. It’s Possible.
Imagine: Ending HIV. It’s Possible is the name of a new, national campaign to encourage and energize the HIV workforce to achieve the national goal of ending the HIV epidemic.Blog updated 06/30/2022
-
Imagine: Ending HIV. It's Possible.
Kickoff of a national campaign to showcase how RWHAP leaders have been innovating to achieve the goal of ending the HIV epidemic.Resource updated 03/15/2023